Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: A randomized, controlled trial

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1018-1024

  Wilkieson, Trevor J ^a   Ingram, Alistair J ^a   Crowther, Mark A ^a   Soroka, Steven D ^b   Nagai, Ryuta ^c   Jindal, Kailash K ^d   Clase, Catherine M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Systeme de sante de Niagara   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CATHETER COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMODIALYSIS CATHETER FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PLACEBOS; RENAL DIALYSIS; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS; WARFARIN;

EID: 79957824749     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07240810     Document Type: Article

References (28)

1. United States Renal Data System. USRDS 2004 Annual Data Report. Available at: www.usrds.org/adr.htm. Accessed January 24, 2011
2. Liangos O, Gul A, Madias NE, Jaber BL: Long-term management of the tunneled venous catheter. Semin Dial 19: 158-164, 2006
3. Beathard GA: Catheter thrombosis. Semin Dial 14: 441-445, 2001
4. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Vascular Access 2006. Am J Kidney Dis 48[Suppl 1]: S176-S273, 2006
5. Develter W, De CA, Van BW, Vanholder R, Lameire N: Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artificial Organs 29: 399-405, 2005
6. Little MA, O'Riordan A, Lucey B, Farrell M, Lee M, Conlon PJ, Walshe JJ: A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 16: 2194-2200, 2001
7. Ponikvar R, Buturovic-Ponikvar J: Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients. Ther Apher Dial 9: 250-253, 2005
8. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R: Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol 9: 859-868, 1998
9. Twardowski ZJ: High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. Am J Kidney Dis 31: 841-847, 1998
10. Akl EA, Yosuico VED, Kim SY, Barba M, Sperati F, Cook D, Schünemann HJ: Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database Syst Rev DOI: 10.1002/14651858.CD006468.pub2. 2007
11. Willms L, Vercaigne LM: Does warfarin safely prevent clotting of hemodialysis catheters? A review of efficacy and safety. Semin Dial 21: 71-77, 2008
12. Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO: A randomized trial of minidose warfarin for the pre-vention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int 59: 1935-1942, 2001
13. Zellweger M, Bouchard J, Raymond-Carrier S, Laforest-Renald A, Querin S, Madore F: Systemic anticoagulation and prevention of hemodialysis catheter malfunction. ASAIO J 51: 360-365, 2005
14. Obialo CI, Conner AC, Lebon LF: Maintaining patency of tunneled hemodialysis catheters: Efficacy of aspirin compared to warfarin. Scand J Urol Nephrol 37: 172-176, 2003
15. Coli L, Donati G, Cianciolo G, Raimondi C, Comai G, Panicali L, Nastasi V, Cannarile DC, Gozzetti F, Piccari M, Stefoni S: Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access 7: 118-122, 2006
16. Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR: Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23: 4063-4069, 2005
17. Curigliano G, Balduzzi A, Cardillo A, Ghisini R, Peruzzotti G, Orlando L, Torrisi R, Dellapasqua S, Lunghi L, Goldhirsch A, Colleoni M: Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter. Supportive Care Cancer 15: 1213-1217, 2007
18. Elliott MJ, Zimmerman D, Holden RM: Warfarin anticoagulation in hemodialysis patients: A systematic review of bleeding rates. Am J Kidney Dis 50: 433-440, 2007
19. Holden RM, Harman GJ, Wang M, Holland D, Day AG: Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 3: 105-110, 2008
20. Chan K, Lazarus J, Thadhani R, Hakim R: Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol 20: 872-881, 2009
21. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M: Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349: 631-639, 2003
22. Oake N, Jennings A, Forster AJ, Fergusson D, Doucette S, van Walraven C: Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: A systematic review and meta-analysis. CMAJ 179: 235-244, 2008
23. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis 37[Suppl 1]: S137-S181, 2001
24. Wiernikowski JT, Crowther M, Clase CM, Ingram AJ, Andrew M, Chan AKC: Determination of stability and sterility of recombinant tissue plasminogen activator (rtPA) at -30° celsius. Lancet 335: 2221-2222, 2000
25. Clase CM, Crowther MA, Ingram AJ, Cina CS: Thrombolysis for restoration of patency to haemodialysis central venous catheters: A systematic review. J Thromb Thrombolysis 11: 127-136, 2001
26. Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A: Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: A randomized trial. JAMA 293: 690-698, 2005
27. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361: 1139-1151, 2009
28. Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR: Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 119: 1616-1624, 2009